The trademark was filed by HengRui, USA Ltd., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 1, 2022, and received one opposition filed on October 9, 2022 by Huvepharma EOOD on Likelihood of confusion. the opponent was represented by Vulchev Ivanov, Deyan and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 9, 2022
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).